Stephen Caplan

1.5k total citations
34 papers, 898 citations indexed

About

Stephen Caplan is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Stephen Caplan has authored 34 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Stephen Caplan's work include Acute Myeloid Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Stephen Caplan is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Stephen Caplan collaborates with scholars based in Canada, United States and United Kingdom. Stephen Caplan's co-authors include E. M. Berkman, Brian Leber, Sarit Assouline, Caroline Rousseau, Katherine L. B. Borden, Biljana Čuljković, Denis‐Claude Roy, Eftihia Cocolakis, Wilson H. Miller and Abdellatif Amri and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen Caplan

33 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Caplan Canada 15 370 320 159 151 134 34 898
Dorit Blickstein Israel 18 185 0.5× 280 0.9× 98 0.6× 199 1.3× 73 0.5× 47 874
Seth A. Rudnick United States 15 132 0.4× 664 2.1× 302 1.9× 205 1.4× 113 0.8× 23 1.3k
Peter A.W. te Boekhorst Netherlands 21 221 0.6× 582 1.8× 263 1.7× 245 1.6× 113 0.8× 50 1.1k
Z. Tellier France 15 198 0.5× 550 1.7× 71 0.4× 87 0.6× 74 0.6× 31 1.1k
Abraham Kornberg Israel 17 189 0.5× 346 1.1× 80 0.5× 106 0.7× 124 0.9× 54 925
Andrija Bogdanović Serbia 17 294 0.8× 466 1.5× 141 0.9× 279 1.8× 162 1.2× 96 894
Sanjay De Mel Singapore 16 332 0.9× 232 0.7× 311 2.0× 101 0.7× 175 1.3× 88 907
Antonia Miñano Spain 18 211 0.6× 498 1.6× 89 0.6× 111 0.7× 73 0.5× 53 875
CA Eekman Netherlands 8 384 1.0× 156 0.5× 465 2.9× 46 0.3× 41 0.3× 8 725
Marta Spreafico Italy 19 157 0.4× 405 1.3× 56 0.4× 122 0.8× 69 0.5× 38 976

Countries citing papers authored by Stephen Caplan

Since Specialization
Citations

This map shows the geographic impact of Stephen Caplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Caplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Caplan more than expected).

Fields of papers citing papers by Stephen Caplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Caplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Caplan. The network helps show where Stephen Caplan may publish in the future.

Co-authorship network of co-authors of Stephen Caplan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Caplan. A scholar is included among the top collaborators of Stephen Caplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Caplan. Stephen Caplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldsmith, Andrew, Nicole M. Duggan, Arun Nagdev, et al.. (2025). National Cost Savings From Use of Artificial Intelligence Guided Echocardiography in the Assessment of Intermediate-Risk Patients With Syncope in the Emergency Department. Journal of the American College of Emergency Physicians Open. 6(3). 100139–100139. 2 indexed citations
2.
Bienz, Marc, et al.. (2021). Severe Cystic Echinococcosis-Associated Immune Thrombocytopenic Purpura: A Case Report. Journal of Hematology. 10(2). 71–75. 2 indexed citations
3.
Bazinet, Alexandre, John A. Heath, Anne‐Sophie Chong, et al.. (2021). Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline CHEK2 variant. Molecular Case Studies. 7(3). a006090–a006090. 3 indexed citations
4.
Assouline, Sarit, Lilian Amrein, Raquel Aloyz, et al.. (2020). IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 61(7). 1653–1659. 6 indexed citations
6.
Assouline, Sarit, Caroline Rousseau, P. Desjardins, et al.. (2010). A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients. Cancer Chemotherapy and Pharmacology. 68(3). 643–651. 11 indexed citations
7.
Rétornaz, F., Johanne Monette, Gerald Batist, et al.. (2008). Usefulness of Frailty Markers in the Assessment of the Health and Functional Status of Older Cancer Patients Referred for Chemotherapy: A Pilot Study. The Journals of Gerontology Series A. 63(5). 518–522. 53 indexed citations
8.
Monette, Johanne, M. Monette, Nadia Sourial, et al.. (2006). O9 Usefulness of frailty markers in the assessment of the health and functional status in older cancer patient referred for chemotherapy: a pilot study. Critical Reviews in Oncology/Hematology. 60. S21–S21. 1 indexed citations
9.
Meyer, Ralph M., M Gyger, Ross Langley, Bernard Lespérance, & Stephen Caplan. (1998). A Phase I Trial of Standard and Cyclophosphamide Dose-Escalated CHOP with Granulocyte Colony Stimulating Factor in Elderly Patients with Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 30(5-6). 591–600. 12 indexed citations
10.
Small, David, et al.. (1995). Tracheoesophageal Fistula as the Initial Presentation of Hodgkinʼs Disease. Southern Medical Journal. 88(6). 664–666. 5 indexed citations
11.
Trudel, Michel, et al.. (1994). Statin—A Novel Marker of Nonproliferation:Expression in Nonneoplastic Lymphoid Tissues and Follicular Lymphomas. American Journal of Clinical Pathology. 101(4). 421–425. 2 indexed citations
12.
Roulston, Anne, Mario D’Addario, F Boulerice, et al.. (1992). Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells.. The Journal of Experimental Medicine. 175(3). 751–763. 43 indexed citations
13.
Trudel, M., et al.. (1991). Large-cell lymphoma presenting with hepatic sinusoidal infiltration.. PubMed. 115(8). 821–4. 7 indexed citations
14.
Caplan, Stephen, et al.. (1989). Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-links. Biochemical Pharmacology. 38(18). 3122–3123. 45 indexed citations
15.
Panasci, Lawrence, et al.. (1988). Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia.. PubMed. 48(7). 1972–6. 41 indexed citations
17.
Berkman, E. M., Richard S. Eisenstaedt, & Stephen Caplan. (1978). Supportive Granulocyte Transfusion in the Infected Severely Neutropenic Patient. Transfusion. 18(6). 693–700. 10 indexed citations
18.
Caplan, Stephen, et al.. (1978). Management of Chronic Myelocytic Leukemia in Pregnancy by Cell Pheresis. Transfusion. 18(1). 120–124. 21 indexed citations
19.
Caplan, Stephen, et al.. (1978). MANAGEMENT OF CHRONIC MYELOCYTIC LEUKEMIA IN PREGNANCY BY CELL PHERESIS. Obstetrical & Gynecological Survey. 33(10). 656–658. 2 indexed citations
20.
Caplan, Stephen & Eugene M. Berkman. (1976). Immunosuppressive Therapy of Idiopathic Thrombocytopenic Purpura. Medical Clinics of North America. 60(5). 971–986. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026